Stay updated on Durvalumab in Resectable Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Durvalumab in Resectable Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab in Resectable Lung Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The Record History for NCT03800134 shows many version updates, with recurring changes to Study Status, Contacts/Locations, and IPDSharing, reflecting ongoing adjustments to trial status and participating sites. These updates affect current participation information and how to contact researchers.
    Difference
    0.1%
    Check dated 2025-11-03T00:44:58.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    35 days ago
    Change Detected
    Summary
    - Added a government operations notice and operating details, plus a new v3.2.0 revision. - Removed the previous v3.1.0 revision.
    Difference
    9%
    Check dated 2025-10-05T06:28:50.000Z thumbnail image
  4. Check
    42 days ago
    Change Detected
    Summary
    Updated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No changes to core content, pricing, or stock are evident.
    Difference
    0.2%
    Check dated 2025-09-28T02:50:36.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2; a 'Back to Top' link was removed as a minor UI change.
    Difference
    0.5%
    Check dated 2025-09-13T13:53:15.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.5%
    Check dated 2025-09-06T04:20:40.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location details, while removing specific location terms and listed countries. This indicates a shift towards a more streamlined presentation of study information.
    Difference
    54%
    Check dated 2025-08-30T01:19:48.000Z thumbnail image

Stay in the know with updates to Durvalumab in Resectable Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab in Resectable Lung Cancer Clinical Trial page.